A Novel Variant in RAD21 in Cornelia De Lange Syndrome Type 4: Case Report and Bioinformatic Analysis.

Cornelia de Lange type 4 RAD21 genotype/phenotype correlation in silico analysis prenatal growth retardation

Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
01 01 2023
Historique:
received: 28 11 2022
revised: 16 12 2022
accepted: 30 12 2022
entrez: 21 1 2023
pubmed: 22 1 2023
medline: 25 1 2023
Statut: epublish

Résumé

Cornelia de Lange Syndrome (CdLS) is a rare genetic disorder that affects many organs. The diagnosis of this condition is primarily clinical and it can be confirmed by molecular analysis of the genes known to cause this disease, although about 30% of CdLS patients are without a genetic diagnosis. Here we report clinical and genetic findings of a patient with CdLS type 4, a syndrome of which the clinical features of only 30 patients have been previously described in the literature. The index patient presented with clinical characteristics previously associated with CdLS type 4 (short nose, thick eyebrow, global development delay, synophrys, microcephaly, weight < 2DS, small hands, height < 2DS). She also presented cardiac anomalies, cleft palate and laryngomalacia, which was never described before. The index patient was diagnosed with a novel

Identifiants

pubmed: 36672860
pii: genes14010119
doi: 10.3390/genes14010119
pmc: PMC9859063
pii:
doi:

Substances chimiques

Cell Cycle Proteins 0
RAD21 protein, human 0
DNA-Binding Proteins 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Nat Protoc. 2015 Jun;10(6):845-58
pubmed: 25950237
Genome Biol. 2016 Jun 06;17(1):122
pubmed: 27268795
Genomics. 1996 Sep 1;36(2):305-15
pubmed: 8812457
Nat Genet. 2006 May;38(5):528-30
pubmed: 16604071
Hum Genet. 2020 May;139(5):575-592
pubmed: 32193685
Am J Hum Genet. 2005 Dec;77(6):1117-28
pubmed: 16380922
Brain. 2020 Aug 1;143(8):e64
pubmed: 32696056
Nat Genet. 2004 Jun;36(6):631-5
pubmed: 15146186
Nat Rev Genet. 2018 Oct;19(10):649-666
pubmed: 29995837
Brain. 2019 Sep 1;142(9):2631-2643
pubmed: 31334757
Am J Hum Genet. 2012 Jun 8;90(6):1014-27
pubmed: 22633399
Hum Mutat. 2015 Apr;36(4):454-62
pubmed: 25655089
Nat Struct Biol. 2003 Dec;10(12):980
pubmed: 14634627
Nat Genet. 2018 Mar;50(3):329-332
pubmed: 29379197
Clin Genet. 2015 Jul;88(1):1-12
pubmed: 25209348
Nat Genet. 2004 Jun;36(6):636-41
pubmed: 15146185
Mol Cell. 2004 Sep 24;15(6):951-64
pubmed: 15383284
Nature. 2012 Sep 13;489(7415):313-7
pubmed: 22885700

Auteurs

Alessandro De Falco (A)

U.O.C. Genetica Medica, A.O.U. Federico II, 80131 Naples, Italy.
Department of Molecular Medicine and Medical Biotechnology, University Federico II, 80131 Naples, Italy.

Daniele De Brasi (D)

U.O.C. Pediatria, AORN Santobono Pausilipon, 80129 Naples, Italy.

Matteo Della Monica (M)

Medical and Laboratory Genetic Unit, Antonio Cardarelli Hospital, 80131 Naples, Italy.

Claudia Cesario (C)

Laboratory of Medical Genetics, Bambino Gesù Children Hospital IRCCS, 00165 Rome, Italy.

Stefano Petrocchi (S)

Laboratory of Medical Genetics, Bambino Gesù Children Hospital IRCCS, 00165 Rome, Italy.

Antonio Novelli (A)

Laboratory of Medical Genetics, Bambino Gesù Children Hospital IRCCS, 00165 Rome, Italy.

Giuseppe D'Alterio (G)

European School of Molecular Medicine, Università Degli Studi di Milano, 20139 Milan, Italy.
CEINGE Biotecnologie Avanzate, 80145 Naples, Italy.

Achille Iolascon (A)

U.O.C. Genetica Medica, A.O.U. Federico II, 80131 Naples, Italy.
Department of Molecular Medicine and Medical Biotechnology, University Federico II, 80131 Naples, Italy.
CEINGE Biotecnologie Avanzate, 80145 Naples, Italy.

Mario Capasso (M)

Department of Molecular Medicine and Medical Biotechnology, University Federico II, 80131 Naples, Italy.
CEINGE Biotecnologie Avanzate, 80145 Naples, Italy.

Carmelo Piscopo (C)

Medical and Laboratory Genetic Unit, Antonio Cardarelli Hospital, 80131 Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH